Zealand Pharma sells insulin pump to Mannkind Corporation

On Tuesday, Zealand Pharma reports that a deal has been struck with US-based Mannkind Corporation entailing the sale of V-Go, an insulin pump. (Updated)
Photo: Zealand Pharma / PR
Photo: Zealand Pharma / PR
by christopher due karlsson, translated by daniel pedersen

Zealand Pharma, a biotech firm publicly listed in Denmark that has been undergoing comprehensive structural changes since March, announced on Tuesday that it has sold its insulin pump, dubbed V-Go, to US-based firm Mannkind Corporation.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading